Stocktoria
ROCKET PHARMACEUTICALS, INC. RCKT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-02-18
ROCKET PHARMACEUTICALS, INC. statistics & valuation
Market cap$354.9M
P / B1.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -67.5% | -49.0% | -43.4% | -40.2% | -34.0% |
| Return on equity | -80.5% | -55.9% | -49.9% | -45.3% | -37.2% |
| Current ratio | 6.38 | 9.30 | 7.80 | 9.29 | 17.69 |
Source: SEC EDGAR filings · CIK 0001281895 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.